Versión de HTML Básico
105
MEMORIA CIENTÍFICA 2012
Gracia-Ahufinger Y, Fariñas MC, García-Almodovar E, Payeras A, Paño-Pardo JR, Muñez-Rubio
E, Carratalá J; the Novel Influenza A (H1N1) Study Group of the Spanish Network for Research
in Infectious Diseases (REIPI) (Segura F, Navarro G.).
Infección Microbiol Clin
. 2012 Nov;18(11):E485-90.
Analysis of transmitted drug resistance in
Spain in the years 2007-2010 documentos a decline in Mutations to the non-nucleoside
clase de drogas
. Monge S, Guillot V, Alvarez M, Peña A, Viciana P, García-Bujalance S, Pérez
Elias MJ, Iribarren JA, Gutiérrez F, Itziar Casado M, Garcia F; Cori (Segura F, Amengual MJ,
Penelo E, Navarro G, Salón M, Cervantes M, Pineda V.).
Infección Microbiol Clin
. 2012 Sep;18(9):894-900.
Impact of changes in CLSI and EUCAST
breakpoints for susceptibility in bloodstream infecciones due to extended-spectrum ß
lactamase-Producing Escherichia coli
. Rodríguez-Baño J, Picón E, Navarro MD, López-
Bodega L, Pascual A; ESBL-REIPI Group (Navarro G.).
Crit Care
. 2012 Aug 3; 16 (4): 145.
The Barcelona Declaration from the World Alliance
against antibióticos Resistance: engagement of intensivista
. Carlet JM, Artigas A, Niederman
MS, Torres A; donde behalf of World Alliance against antibióticos Resistance.
Crit Care
. 2012 Nov 18; 16 (6): R223.
Antibiótico prescription patterns in the empírico therapy
of severe sepsis: combination of antimicrobiales with different mechanisms of action
reduc Mortality
. Díaz-Martín A, Martínez-González ML, Ferrer R, Ortiz-Leyba C, Piacentini
E, Lopez-Pueyo MJ, Martín-Loeches Y, Levy MM, Artigas A, Garnacho-Montero J; for the
Edusepsis Study Group.
Curr HIV Nada
. 2012 diciembre 1; 10 (8): 673-8.
Switching to Raltegravir in Virologically Suppressed
in HIV-1-Infected Patients: En Retrospective, Multicenter, Descriptive Study
. Podzamczer
D, Martínez E, Domingo P, Ferrer E, Viciana P, Curto J, Pérez-Elías MJ, Ocampo A, Santos I,
Knobel H, Estrada V, Negredo E, Segura F, Portilla J, Ribera E, Galindo J, Antela A, Carmena
J, Castaño M, The Toral Study Group.
Enfermo infección microbiol Clin
. 2012 Jun; 30 Suppl 3: 33-8.
Device-associated infección ratas in
Adulto Intensive Care Unidos in Catalonia: VINCat Program findings
. Vallès J, Limón E, Díaz
E, Fernández I, Palomar M, Barcenilla F, Alvarez-Lerma F, Colina M; VINCat Program.
Enfermo infección microbiol Clin
. 2012 Jun; 30 Suppl 3: 43-51.
Antibiótico consumption at 46
VINCat hospitales from 2007 to 2009, Stratified by hospital size and clinical services
. grado
S, Fondevilla Y, Mojal S, Palomar M, Vallès J, Gudiol F; VINCat Antimicrobial Group.
Enfermo infección microbiol Clin
. 2012 Nov;30(9):517-27.
[Cardiovascular risk in human
immunodeficiency virus-Infected patients in Spain. Cori cohorte, 2011]
. Masiá M, Pérez
Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, Blanco JR, Peña A, Rodríguez
F, Vera M, Del Amo J, Gutiérrez F; Grupo de estudio de riesgo cardiovascular de Coria
(Navarro G.).